# Multi-center, Single Blinded, RCT, Pivotal Study to Evaluate the Efficacy and Safety of DTx to Improve ADHD

> **NCT07173439** · NA · COMPLETED · sponsor: **EMOTIV** · enrollment: 120 (actual)

## Conditions studied

- ADHD - Attention Deficit Disorder With Hyperactivity
- ADHD - Combined Type
- ADHD

## Interventions

- **DEVICE:** Model Name: EMT-SR01;red
- **DEVICE:** Model Name: EMT-SR01;red (Placebo)

## Key facts

- **NCT ID:** NCT07173439
- **Lead sponsor:** EMOTIV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-15
- **Primary completion:** 2025-05-13
- **Final completion:** 2025-05-13
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173439, "Multi-center, Single Blinded, RCT, Pivotal Study to Evaluate the Efficacy and Safety of DTx to Improve ADHD". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT07173439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*